Literature DB >> 19837947

Differential phosphoinositide 3-kinase signaling: implications for PTCA?

Petra Rocic.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19837947      PMCID: PMC3124260          DOI: 10.1152/ajpheart.00952.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


× No keyword cloud information.
  6 in total

1.  p85 regulatory subunit of PI3K mediates cAMP-PKA and estrogens biological effects on growth and survival.

Authors:  C Cosentino; M Di Domenico; A Porcellini; C Cuozzo; G De Gregorio; M R Santillo; S Agnese; R Di Stasio; A Feliciello; A Migliaccio; E V Avvedimento
Journal:  Oncogene       Date:  2006-10-02       Impact factor: 9.867

Review 2.  Signalling through Class I PI3Ks in mammalian cells.

Authors:  P T Hawkins; K E Anderson; K Davidson; L R Stephens
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

Review 3.  Phosphoinositide 3-kinase signalling in the vascular system.

Authors:  Fulvio Morello; Alessia Perino; Emilio Hirsch
Journal:  Cardiovasc Res       Date:  2008-11-26       Impact factor: 10.787

4.  Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K.

Authors:  Daniele Torella; Cosimo Gasparri; Georgina M Ellison; Antonio Curcio; Angelo Leone; Carla Vicinanza; Valentina Galuppo; Isabella Mendicino; Walter Sacco; Iolanda Aquila; Francesca Chiara Surace; Maria Luposella; Gilda Stillo; Valter Agosti; Claudia Cosentino; Enrico V Avvedimento; Ciro Indolfi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-25       Impact factor: 4.733

Review 5.  Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system.

Authors:  Donald H Maurice; Daniel Palmer; Douglas G Tilley; Heather A Dunkerley; Stuart J Netherton; Daniel R Raymond; Hisham S Elbatarny; Sandra L Jimmo
Journal:  Mol Pharmacol       Date:  2003-09       Impact factor: 4.436

Review 6.  Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.

Authors:  Lisa T Newsome; Michael A Kutcher; Roger L Royster
Journal:  Anesth Analg       Date:  2008-08       Impact factor: 5.108

  6 in total
  1 in total

1.  Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.

Authors:  Yufeng Yao; Zhenkun Hu; Jian Ye; Changqing Hu; Qixue Song; Xingwen Da; Yubin Yu; Hui Li; Chengqi Xu; Qiuyun Chen; Qing Kenneth Wang
Journal:  J Am Heart Assoc       Date:  2017-06-25       Impact factor: 5.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.